The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Dendreon Announces Strong Commercial Start to 2015

January 14, 2015 4:13 pm | News | Comments

Dendreon Corporation today announced that the company grew sales in four quarters successively, exceeded its revenue target for the first time ever, and achieved cash-flow break even in the fourth quarter (adjusted for non-recurring items), starting 2015 on a strong footing.


Sunovion Pharmaceuticals Files Patent Infringement Lawsuits Regarding Latuda®

January 14, 2015 4:09 pm | News | Comments

Sunovion Pharmaceuticals has filed patent infringement lawsuits against Emcure Pharmaceuticals Limited, Emcure Pharmaceuticals USA, Inc., and InvaGen Pharmaceuticals Inc. regarding their submissions of Abbreviated New Drug Applications for generic copies of Latuda®.


Oklahoma, Florida Lethal Injections to Use Same Method

January 14, 2015 4:02 pm | by SEAN MURPHY, Associated Press | News | Comments

The drug mixture begins with the sedative midazolam and includes the same drugs used in Oklahoma's botched execution of Clayton Lockett in April. Lockett writhed on the gurney and moaned after he'd been declared unconscious.     


Does the Measles Vaccine Work?

January 14, 2015 8:47 am | Videos | Comments

CBS News chief medical correspondent Dr. Jon LaPook and medical contributor Dr. Tara Narula talk about the measles vaccine and how effective vaccines can be years after the drug is administered.          


Vical and AnGes to Develop Therapy for Ebola Virus

January 14, 2015 8:38 am | News | Comments

Vical Incorporated and AnGes MG announced today that they have entered into collaboration to develop and commercialize an equine polyclonal antibody therapy for patients afflicted with Ebola virus disease. No medicines or vaccines are currently approved for the treatment of Ebola.


SGS Expands Biomarker Services

January 14, 2015 8:28 am | News | Comments

SGS Life Science Services today announced that its laboratory in Poitiers, France, has successfully completed a full analytical validation of the novel Meso Scale Discovery (MSD®) V-PLEX 10-plex Proinflammatory Panel I, for use with human plasma samples.


AstraZeneca’s BRILINTA® Meets Primary Endpoint in Both 60mg and 90mg Doses

January 14, 2015 8:19 am | News | Comments

The study assessed BRILINTA® (ticagrelor) tablets at either 60mg twice daily or 90mg twice daily plus low-dose aspirin for the secondary prevention of atherothrombotic events in patients who had experienced a heart attack one to three years prior to study start.


US Job Openings at Fourteen-Year High

January 14, 2015 8:10 am | by CHRISTOPHER S. RUGABER, AP Economics Writer | News | Comments

U.S. employers advertised the most job openings in nearly 14 years in November, the Labor Department said Tuesday. That suggests businesses are determined to keep adding staff because they are confident strong economic growth will create more demand for their goods and services.


No Sign of Ebola for CDC Lab Worker Feared Exposed Weeks Ago

January 13, 2015 4:16 pm | by MIKE STOBBE, AP Medical Writer | News | Comments

Health officials say a federal laboratory technician who was possibly exposed to the Ebola virus did not get sick. Officials on Tuesday said the employee at the Centers for Disease Control and Prevention hasn't shown any symptoms since the incident Dec. 22.


Steel-Studded Pill May Signal the End of Injections

January 13, 2015 2:39 pm | by Mike Auerbach, Editor In Chief | Videos | Comments

Drug bioavailability is a major concern for all pharmaceutical companies. Being able to deliver the therapeutic benefits of the treatment at the right dosage and at the correct time and for the proper duration is a major stumbling block for any drug development program.


Roche, Meiji and Fedora to Collaborate on New Antibiotic to Fight Increasing Bacterial Resistance

January 13, 2015 11:26 am | News | Comments

Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the development and commercialization of OP0595, a beta-lactamase inhibitor in phase I clinical development. Under the agreement, Roche obtains worldwide rights from both companies for development and commercialization with the exception of Japan, where Meiji will retain sole commercialization rights.


Judge Cuts Damages for Teacher Fired for In Vitro Treatment

January 13, 2015 11:11 am | News | Comments

A federal judge has significantly reduced the nearly $2 million in damages awarded to a former teacher fired by a Roman Catholic diocese for trying to get pregnant through in vitro fertilization.         


GlobalData: Rheumatoid Arthritis Treatment Market to be Transformed by Novel Drug and Biosimilar Launches

January 13, 2015 11:03 am | News | Comments

The global Rheumatoid Arthritis (RA) treatment market value will witness steady growth, from $15.6 billion in 2013 to $19.3 billion in 2023, at a Compound Annual Growth Rate (CAGR) of 2.1%, according to research and consulting firm GlobalData. 


Photo of the Day - Medical Marijuana

January 13, 2015 10:55 am | by Mike Auerbach, Editor In Chief | News | Comments

While Colorado and Washington have become ground zero for the incredible growth in legal marijuana usage, the states have also become safe havens for those that need easy access to medical marijuana.         


Pharmacyclics Reports Good Revenue from Imbruvica

January 13, 2015 9:38 am | by The Associated Press | News | Comments

Shares of Pharmacyclics jumped Tuesday morning after the cancer treatment developer announced better-than-expected revenue forecasts for Imbruvica, a leukemia drug it sells with a Johnson & Johnson subsidiary.      



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.